KYLAN POULLARD: Open Payments
NPI 1780268516 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 8 payments from 6 companies in 2025. Trend: 2023 $286 · 2024 $212 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Sight Sciences, Inc. | 2 | $93 |
| Tandem Diabetes Care, Inc. | 2 | $78 |
| Dexcom, Inc. | 1 | $60 |
| Dompe US, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
Products named: Ozempic, OMNI SURGICAL SYSTEM, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, OXERVATE, DURYSTA.
Industry payments across LA — which companies pay providers there.
